1. Home
  2. MDGL vs ALTR Comparison

MDGL vs ALTR Comparison

Compare MDGL & ALTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • ALTR
  • Stock Information
  • Founded
  • MDGL 2011
  • ALTR 1985
  • Country
  • MDGL United States
  • ALTR United States
  • Employees
  • MDGL N/A
  • ALTR N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • ALTR Computer Software: Prepackaged Software
  • Sector
  • MDGL Health Care
  • ALTR Technology
  • Exchange
  • MDGL Nasdaq
  • ALTR Nasdaq
  • Market Cap
  • MDGL 7.4B
  • ALTR 8.8B
  • IPO Year
  • MDGL N/A
  • ALTR 2017
  • Fundamental
  • Price
  • MDGL $325.99
  • ALTR $104.38
  • Analyst Decision
  • MDGL Buy
  • ALTR Hold
  • Analyst Count
  • MDGL 14
  • ALTR 8
  • Target Price
  • MDGL $347.33
  • ALTR $100.71
  • AVG Volume (30 Days)
  • MDGL 654.8K
  • ALTR 1.7M
  • Earning Date
  • MDGL 10-31-2024
  • ALTR 10-30-2024
  • Dividend Yield
  • MDGL N/A
  • ALTR N/A
  • EPS Growth
  • MDGL N/A
  • ALTR N/A
  • EPS
  • MDGL N/A
  • ALTR 0.38
  • Revenue
  • MDGL $76,813,000.00
  • ALTR $644,660,000.00
  • Revenue This Year
  • MDGL N/A
  • ALTR $9.00
  • Revenue Next Year
  • MDGL $193.46
  • ALTR $8.81
  • P/E Ratio
  • MDGL N/A
  • ALTR $272.09
  • Revenue Growth
  • MDGL N/A
  • ALTR 7.15
  • 52 Week Low
  • MDGL $168.25
  • ALTR $68.87
  • 52 Week High
  • MDGL $368.29
  • ALTR $113.12
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 62.52
  • ALTR 59.08
  • Support Level
  • MDGL $272.72
  • ALTR $103.51
  • Resistance Level
  • MDGL $323.99
  • ALTR $104.87
  • Average True Range (ATR)
  • MDGL 19.26
  • ALTR 0.57
  • MACD
  • MDGL -2.73
  • ALTR -0.41
  • Stochastic Oscillator
  • MDGL 48.41
  • ALTR 51.44

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.

About ALTR Altair Engineering Inc.

Altair Engineering Inc is a provider of enterprise-class engineering software enabling origination of the entire product lifecycle from concept design to in-service operation. The integrated suite of software provided by the company optimizes design performance across multiple disciplines encompassing structures, motion, fluids, thermal management, system modeling, and embedded systems. It operates through two segments: Software which includes the portfolio of software products such as solvers and optimization technology products, modeling and visualization tools, industrial and concept design tools, and others; and Client Engineering Services which provides client engineering services to support customers. Majority of its revenue comes from the software segment.

Share on Social Networks: